Achieved Outputs
*data updated on Oct. 2025
1 / Clinically 50%
-
To develop and test Class III bioactive, implantable, or injectable bioengineering products for orthopaedic applications
-
The design bases on the transformation of preclinical validations to patients to facilitate the bone regeneration in challenging musculoskeletal conditions with impaired osteogenic potential.
2 / Scientifically 70%
-
To advance R&D of Class III innovative biodegradable materials and implants that offer initial fixation and create a supportive microenvironment for bone regeneration and remodeling during degradation.
-
Advanced biotechnologies will be used to study cells-material matrix-biophysical signal interactions and mechanisms during skeletal defect repair, helping optimize treatment and improve effectiveness.
3 / Educationally 65%
-
To establish a multidisciplinary platform and curriculum to educate students and to share our scientific results with other scientists and researchers for facilitating translational research.
-
The junior faculties (i.e. RAPs) involved in this project gain more mature directions, and they will grow up as the next generation for this clinically important field.